Monday, March 20, 2017 3:00:07 PM
Recent ESPR News
- Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/08/2024 09:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:22:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 12:22:16 PM
- U.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices Drop • IH Market News • 11/07/2024 11:19:35 AM
- Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 11/07/2024 11:00:00 AM
- Esperion to Participate in Upcoming Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/04/2024 01:00:25 PM
- Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions • GlobeNewswire Inc. • 10/31/2024 12:00:00 PM
- Esperion to Report Third Quarter 2024 Financial Results on November 7 • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/22/2024 10:06:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 08:08:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/17/2024 07:25:29 PM
- Esperion EU Partner Reports Final Real-World Results from MILOS German Cohort Demonstrating Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid • GlobeNewswire Inc. • 10/02/2024 12:00:00 PM
- Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/25/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:12:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:11:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:02:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 07:28:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 07:20:06 PM
- Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:03:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/19/2024 07:50:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/12/2024 08:33:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:08:30 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM